ASK1-IN-2 is a potent, orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), demonstrating an IC50 of 32.8 nM. It has shown therapeutic potential in preclinical research for ulcerative colitis, with studies investigating its effects in both cellular assays and animal models of inflammatory disease.